WEBINAR VIDEO | Life Sciences Session #9: Hot topics in healthcare tendering

WEBINAR VIDEO | Life Sciences Session #9: Hot topics in healthcare tendering
November 28, 2022

Please join us on 28 November 2022 from 13:30 to 14:30 for our ninth online Life Sciences Session, where Caroline De Mulder and Kirian Claeyé will discuss the latest evolutions in the field of healthcare public procurement and will answer questions such as:

  • Is a supplier entitled to indexation of its prices due to the current economic crisis?
  • What’s the impact of the new article 71bis of the law of 14 July 1994 concerning the compulsory insurance for medical care and benefits (in Dutch: “ZIV-wet”, in French: “loi AMI”) on tendering for biologicals and biosimilars?
  • In which context can suppliers offer benefits to the contracting hospitals?

Contact

  • Kirian Claeyé

    Partner

Recommended articles

August 10, 2026

Belgian Pharma Law Summer Blog Series (Part 3): the recently passed ‘Bill containing various provisions on health’

In our Belgian Pharma Law Summer Blog Series, we examine recent developments in Belgian pharmaceutical law. Whether you are looking for an informative summer read or a concise overview of the latest legal developments to catch up on after the holidays, our series has you covered. Our third and final part examines the ‘Bill containing […]

Read on
August 03, 2026

Belgian Pharma Law Summer Blog Series (Part 2): the new ‘Article 10 guidance’ on pharmaceutical promotion

In our Belgian Pharma Law Summer Blog Series, we examine recent developments in Belgian pharmaceutical law. Whether you are looking for an informative summer read or a concise overview of the latest legal developments to catch up on after the holidays, our series has you covered. Part 2 focuses on the new guidance on the […]

Read on
July 27, 2026

Belgian Pharma Law Summer Blog Series (Part 1): the Act of 30 May 2026 containing various provisions on medicinal and health products

In our Belgian Pharma Law Summer Blog Series, we examine recent developments in Belgian pharmaceutical law. Whether you are looking for an informative summer read or a concise overview of the latest legal developments to catch up on after the holidays, our series has you covered. Part 1 focuses on the Act of 30 May […]

Read on